Pfizer Inc.PFENYSE
Loading
Revenue minus cost of goods sold
3Y CAGR
-10.8%/yr
vs +13.3%/yr prior
5Y CAGR
+8.1%/yr
Recent deceleration
Acceleration
-24.2pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $44.01B | +5.2% |
| 2024 | $41.85B | +37.9% |
| 2023 | $30.34B | -51.1% |
| 2022 | $62.09B | +32.5% |
| 2021 | $46.88B | +56.9% |
| 2020 | $29.88B | +4.7% |
| 2019 | $28.55B | -24.2% |
| 2018 | $37.64B | +2.4% |
| 2017 | $36.77B | -0.3% |
| 2016 | $36.87B | - |